Correction: Separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and perfusion in people with type 2 diabetes: a randomised trial.

Gullaksen, Søren; Vernstrøm, Liv; Sørensen, Steffen S; Ringgaard, Steffen; Laustsen, Christoffer; Funck, Kristian L; Poulsen, Per L; Laugesen, Esben

Gullaksen, Søren; Vernstrøm, Liv; Sørensen, Steffen S; Ringgaard, Steffen; Laustsen, Christoffer; Funck, Kristian L; Poulsen, Per L; Laugesen, Esben.

Afiliação

Gullaksen S; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark. soegul@clin.au.dk.
Vernstrøm L; Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark. soegul@clin.au.dk.
Sørensen SS; Steno Diabetes Center Aarhus, Aarhus University Hospital, Aarhus, Denmark. soegul@clin.au.dk.
Ringgaard S; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Laustsen C; Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark.
Funck KL; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Poulsen PL; Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark.
Laugesen E; Department of Clinical Medicine, The MR Research Centre, Aarhus University, Aarhus, Denmark.

Diabetologia ; 67(7): 1451, 2024 Jul.

Article em En | MEDLINE | ID: mdl-38739291

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article